ESRD
Conditions
Keywords
glycated hemoglobin, mean plasma glucose
Brief summary
The investigators are studying the correlation between Hba1c and the mean plasma glucose in diabetic hemodialysis patients.We are reviewing if HbA1c is a good clinical tool to assess glycemic control over a 3 months duration in hemodialysis patients
Detailed description
The Hb turnover in hemodialysis population is higher than the general population leading to a general believe that HbA1c tend to underestimate mean plasma glucose. The investigators are trying to define the correlation between mean plasma glucose and HbA1c in the hemodialysis population and trying to study the factors that could affect this correlation (dose of erythropoetin, ret count..) We are trying to see if HbA1c is a better tool to assess glycemic control over 1 month than glycemic control over 3 month. This clinicaly will translate in obtaining HbA1c more frequently in hemodialysis patients to assess their glycemic control.
Interventions
None listed
Sponsors
Northwell Health
Study design
Observational model
CASE_CROSSOVER
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age\>18 * Hemodialysis and diabetic * Lab data are available for more than 6 months
Exclusion criteria
* Lab data not available
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measure levels of plasma blood glucose and HbA1c | 6 month intervals |
Secondary
| Measure | Time frame |
|---|---|
| Measure ferritin, erythropoetin dose, reticulocytes count | 6 month intervals |
Countries
United States
Outcome results
None listed